Central and peripheral administration of human relaxin-2 to adult male rats inhibits food intake

Diabetes, Obesity and Metabolism

Volumn 12, Issue 12, 2010, Pages 1090-1096

  McGowan, B M C ^a   Minnion, J S ^b   Murphy, K G ^b   White, N E ^b   Roy, D ^b   Stanley, S A ^b   Dhillo, W S ^b   Gardiner, J V ^b   Ghatei, M A ^b   Bloom, S R ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Appetite; Appetite control; Neuropharmacology; Paraventricular nucleus; Relaxin; RXFP 1

Indexed keywords

RELAXIN; RELAXIN 2; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; GROOMING; HORMONAL REGULATION; MALE; NONHUMAN; RAT; THALAMUS MIDLINE NUCLEUS;

EID: 77958576289     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2010.01302.x     Document Type: Article

References (39)

1. Bathgate RA, Samuel CS, Burazin TC, Gundlach AL, Tregear GW. Relaxin: new peptides, receptors and novel actions. Trends Endocrinol Metab 2003; 14: 207-213.
2. Sherwood OD. Relaxin's physiological roles and other diverse actions. Endocr Rev 2004; 25: 205-234.
3. Callander GE, Bathgate RA. Relaxin family peptide systems and the central nervous system. Cell Mol Life Sci 2010; 67: 2327-2341.
4. Sunn N, Egli M, Burazin TC et al. Circulating relaxin acts on subfornical organ neurons to stimulate water drinking in the rat. Proc Natl Acad Sci U S A 2002; 99: 1701-1706.
5. Gunnersen JM, Crawford RJ, Tregear GW. Expression of the relaxin gene in rat tissues. Mol Cell Endocrinol 1995; 110: 55-64.
6. Osheroff PL, Ho WH. Expression of relaxin mRNA and relaxin receptors in postnatal and adult rat brains and hearts. Localization and developmental patterns. J Biol Chem 1993; 268: 15193-15199.
7. Burazin TCD, Davern P, McKinley MJ, Tregear G. Identification of relaxin and relaxin responsive cells in the rat brain. Proceedings of the Third International Conference on Relaxin and Related Peptides. Dordrecht, London: Kluwer Academic Publishers, 2000; 209-214.
8. Burazin TC, Johnson KJ, Ma S, Bathgate RA, Tregear GW, Gundlach AL. Localization of LGR7 (Relaxin Receptor) mRNA and protein in rat forebrain: Correlation with relaxin binding site distribution. Ann N Y Acad Sci 2005; 1041: 205-210.
9. Ma S, Roozendaal B, Burazin TC, Tregear GW, McGaugh JL, Gundlach AL. Relaxin receptor activation in the basolateral amygdala impairs memory consolidation. Eur J Neurosci 2005; 22: 2117-2122.
10. Hsu SY, Nakabayashi K, Nishi S et al. Activation of orphan receptors by the hormone relaxin. Science 2002; 295: 671-674.
11. Ma S, Shen PJ, Burazin TC, Tregear GW, Gundlach AL. Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [33P]-relaxin binding sites in rat brain: restricted somatic co-expression a clue to relaxin action? Neuroscience 2006; 141: 329-344.
12. Osheroff PL, Phillips HS. Autoradiographic localization of relaxin binding sites in rat brain. Proc Natl Acad Sci U S A 1991; 88: 6413-6417.
13. Piccenna L, Shen PJ, Ma S et al. Localization of LGR7 gene expression in adult mouse brain using LGR7 knock-out/LacZ knock-in mice: correlation with LGR7 mRNA distribution. Ann N Y Acad Sci 2005; 1041: 197-204.
14. Bogatcheva NV, Truong A, Feng S, Engel W, Adham IM, Agoulnik AI. GREAT/LGR8 is the only receptor for insulin-like 3 peptide. Mol Endocrinol 2003; 17: 2639-2646.
15. Sedaghat K, Shen PJ, Finkelstein DI, Henderson JM, Gundlach AL. Leucine-rich repeat-containing G-protein-coupled receptor 8 in the rat brain: Enrichment in thalamic neurons and their efferent projections. Neuroscience 2008; 156: 319-333.
16. Gundlach AL, Ma S, Sang Q et al. Relaxin family peptides and receptors in mammalian brain. Ann N Y Acad Sci 2009; 1160: 226-235.
17. Bathgate RA, Lin F, Hanson NF et al. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry 2006; 45: 1043-1053.
18. Kamat AA, Feng S, Bogatcheva NV, Truong A, Bishop CE, Agoulnik AI. Genetic targeting of relaxin and insulin-like factor 3 receptors in mice. Endocrinology 2004; 145: 4712-4720.
19. Stanley S, Wynne K, McGowan B, Bloom S. Hormonal regulation of food intake. Physiol Rev 2005; 85: 1131-1158.
20. McGowan BM, Stanley SA, Smith KL et al. Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 2005; 146: 3295-3300.
21. McGowan BM, Stanley SA, Smith KL et al. Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul Pept 2006; 136: 72-77.
22. Seal LJ, Small CJ, Dhillo WS et al. PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus. Endocrinology 2001; 142: 4236-4243.
23. Abbott CR, Rossi M, Wren AM et al. Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology 2001; 142: 3457-3463.
24. Druce MR, Minnion JS, Field BC et al. Investigation of structure-activity relationships of Oxyntomodulin (Oxm) using Oxm analogs. Endocrinology 2009; 150: 1712-1722.
25. Sinnayah P, Burns P, Wade JD, Weisinger RS, McKinley MJ. Water drinking in rats resulting from intravenous relaxin and its modification by other dipsogenic factors. Endocrinology 1999; 140: 5082-5086.
26. Banks WA. Blood-brain barrier and energy balance. Obesity (Silver Spring) 2006; 14(Suppl. 5): 234S-237S.
27. Broadwell RD, Brightman MW. Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood. J Comp Neurol 1976; 166: 257-283.
28. Fry M, Ferguson AV. The sensory circumventricular organs: brain targets for circulating signals controlling ingestive behavior. Physiol Behav 2007; 91: 413-423.
29. Miselis RR, Hyde TM, Shapiro RE. Area postrema and adjacent solitary nucleus in water and energy balance. Fed Proc 1984; 43: 2969-2971.
30. Pulman KJ, Fry WM, Cottrell GT, Ferguson AV. The subfornical organ: a central target for circulating feeding signals. J Neurosci 2006; 26: 2022-2030.
31. Silverman AJ, Hoffman DL, Zimmerman EA. The descending afferent connections of the paraventricular nucleus of the hypothalamus (PVN). Brain Res Bull 1981; 6: 47-61.
32. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986; 7: 1189-1192.
33. Scott DJ, Layfield S, Riesewijk A, Morita H, Tregear GW, Bathgate RA. Identification and characterization of the mouse and rat relaxin receptors as the novel orthologues of human leucine-rich repeat-containing G-protein-coupled receptor 7. Clin Exp Pharmacol Physiol 2004; 31: 828-832.
34. Nunez A, Cervera-Ferri A, Olucha-Bordonau F, Ruiz-Torner A, Teruel V. Nucleus incertus contribution to hippocampal theta rhythm generation. Eur J Neurosci 2006; 23: 2731-2738.
35. Summerlee AJ, Hornsby DJ, Ramsey DG. The dipsogenic effects of rat relaxin: the effect of photoperiod and the potential role of relaxin on drinking in pregnancy. Endocrinology 1998; 139: 2322-2328.
36. Gispen WH, Isaacson RL. ACTH-induced excessive grooming in the rat. Pharmacol Ther 1981; 12: 209-246.
37. Torres SJ, Nowson CA. Relationship between stress, eating behavior, and obesity. Nutrition 2007; 23: 887-894.
38. Sunter D, Morgan I, Edwards CM et al. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res 2001; 907: 27-34.
39. Jaszberenyi M, Bagosi Z, Thurzo B, Foldesi I, Telegdy G. Endocrine and behavioral effects of neuromedin S. Horm Behav 2007; 52: 631-639.